title: Biomarker testing for ovarian cancer: clinical utility of multiplex assays.
abstract: The improved detection of ovarian cancer at the earliest stages of development would confer a significant benefit in the therapeutic efficacy and overall survival associated with this devastating disease. The inadequate performance of currently used imaging modalities and the CA 125 biomarker test have precluded the establishment of screening programs and hindered the development of diagnostic tests for ovarian cancer. Two recently completed large clinical trials of ovarian cancer screening have reported findings of mixed impact, further clouding the issue. Considerable effort has been applied to the development of multiplexed biomarker-based tests and the most recent advances are discussed here. Within the clinical setting of pelvic mass differential diagnosis and triage, several significant advancements have been achieved recently, including the US Food and Drug Administration-approved Risk of Ovarian Malignancy Algorithm and OVA1 tests. The development and evaluation of those tests are described in this review. Thus while effective routine screening for ovarian cancer remains a lofty goal, advancement within the clinical management of pelvic mass diagnoses appears to be near at hand.
authors.affiliation: University of Pittsburgh Cancer Institute, Hillman Cancer Center, 5117 Centre Avenue 1.18, Pittsburgh, PA 15213, USA. nolanb@upmc.edu
authors.forename: Brian M
authors.initials: BM
authors.lastname: Nolen
authors.forename: Anna E
authors.initials: AE
authors.lastname: Lokshin
mesh_terms: D000368:Aged; D000465:Algorithms; D016632:Apolipoprotein A-I / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D002986:Clinical Trials as Topic; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D007118:Immunoassay; D013058:Mass Spectrometry; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis*; D011228:Prealbumin / Q000032:analysis*
chemical_list: C505693:APOA1 protein, human; D016632:Apolipoprotein A-I; D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D011228:Prealbumin
references.citation: Gynecol Oncol. 2013 Feb;128(2):233-8
references.pmid: 23200911
references.citation: Obstet Gynecol. 2011 Aug;118(2 Pt 1):280-288
references.pmid: 21775843
references.citation: Clin Cancer Res. 2008 Feb 15;14(4):1065-72
references.pmid: 18258665
references.citation: Am J Obstet Gynecol. 2010 Sep;203(3):228.e1-6
references.pmid: 20471625
references.citation: PLoS One. 2012;7(9):e44960
references.pmid: 22970327
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7574; author reply 7577-9
references.pmid: 18948385
references.citation: Gynecol Oncol. 1992 Nov;47(2):203-9
references.pmid: 1468698
references.citation: Biomark Insights. 2007 Oct 16;2:369-75
references.pmid: 19662218
references.citation: Proc Natl Acad Sci U S A. 2005 May 24;102(21):7677-82
references.pmid: 15890779
references.citation: Cancer Res. 2004 Aug 15;64(16):5882-90
references.pmid: 15313933
references.citation: Clin Cancer Res. 2008 Nov 15;14(22):7574; author reply 7577-9
references.pmid: 18948386
references.citation: JAMA. 2011 Jun 8;305(22):2295-303
references.pmid: 21642681
references.citation: Lancet Oncol. 2009 Apr;10(4):327-40
references.pmid: 19282241
references.citation: J Natl Cancer Inst. 2010 Jan 6;102(1):26-38
references.pmid: 20042715
references.citation: Obstet Gynecol. 2011 Jun;117(6):1298-1306
references.pmid: 21555961
references.citation: J Clin Oncol. 2002 Mar 1;20(5):1248-59
references.pmid: 11870167
references.citation: Cancer Prev Res (Phila). 2011 Mar;4(3):365-74
references.pmid: 21372036
references.citation: Br J Cancer. 2009 Apr 21;100(8):1315-9
references.pmid: 19337252
references.citation: Hematol Oncol Clin North Am. 2003 Aug;17(4):989-1005, ix
references.pmid: 12959188
references.citation: CMAJ. 2004 Aug 17;171(4):323-4
references.pmid: 15313987
references.citation: Clin Chem Lab Med. 2011 Mar;49(3):521-5
references.pmid: 21288178
references.citation: Eur J Cancer. 2012 Jul;48(11):1649-56
references.pmid: 22226481
references.citation: Cancer Res. 2005 Mar 15;65(6):2162-9
references.pmid: 15781627
references.citation: J Clin Oncol. 2010 May 1;28(13):2159-66
references.pmid: 20368574
references.citation: PLoS One. 2009;4(2):e4599
references.pmid: 19240799
references.citation: Gynecol Oncol. 2010 Mar;116(3):378-83
references.pmid: 19945742
references.citation: Int J Gynecol Cancer. 2011 Jul;21(5):852-8
references.pmid: 21633297
references.citation: Clin Chim Acta. 2011 Jul 15;412(15-16):1447-53
references.pmid: 21557935
references.citation: Gynecol Oncol. 2013 Feb;128(2):239-44
references.pmid: 23063998
references.citation: Int J Gynaecol Obstet. 1998 May;61(2):203-4
references.pmid: 9639230
references.citation: Am Fam Physician. 2005 Feb 15;71(4):759-62
references.pmid: 15756773
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):2995-9
references.pmid: 20962299
references.citation: Gynecol Oncol. 2010 Jun;117(3):440-5
references.pmid: 20334903
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2496-506
references.pmid: 22028406
references.citation: Obstet Gynecol. 2009 Apr;113(4):775-782
references.pmid: 19305319
references.citation: Int J Cancer. 2013 May 1;132(9):2127-33
references.pmid: 23065684
references.citation: Gynecol Oncol. 2008 Feb;108(2):402-8
references.pmid: 18061248
references.citation: Cancer Prev Res (Phila). 2012 Aug;5(8):1015-24
references.pmid: 22750949
references.citation: Am J Obstet Gynecol. 2011 Oct;205(4):358.e1-6
references.pmid: 21722869
references.citation: J Clin Oncol. 2004 Oct 15;22(20):4059-66
references.pmid: 15381683
references.citation: Asian Pac J Cancer Prev. 2010;11(1):111-6
references.pmid: 20593939
references.citation: J Clin Oncol. 2005 Nov 1;23(31):7919-26
references.pmid: 16258091
references.citation: Int J Gynecol Cancer. 2012 Feb;22(2):238-44
references.pmid: 22214964
references.citation: Int J Oncol. 2001 Sep;19(3):537-42
references.pmid: 11494033
references.citation: J Cancer Res Clin Oncol. 2010 Jul;136(7):1079-88
references.pmid: 20082099
references.citation: Ultrasound Q. 2010 Dec;26(4):219-23
references.pmid: 21084936
references.citation: Cancer. 2012 Jan 1;118(1):91-100
references.pmid: 21717433
references.citation: PLoS One. 2008 Jul 09;3(7):e2633
references.pmid: 18612378
references.citation: Clin Chem Lab Med. 2011 Mar;49(3):527-34
references.pmid: 21320028
references.citation: Int J Gynecol Cancer. 2012 May;22 Suppl 1:S24-6
references.pmid: 22543916
references.citation: Gynecol Oncol. 2011 Jun 1;121(3):487-91
references.pmid: 21420727
references.citation: Semin Surg Oncol. 1994 Jul-Aug;10(4):242-8
references.pmid: 8091065
references.citation: Ann Fam Med. 2004 May-Jun;2(3):260-2
references.pmid: 15209204
references.citation: Toxicol Pathol. 2012 Oct;40(7):1049-62
references.pmid: 22581811
references.citation: Anticancer Res. 2012 Sep;32(9):4137-40
references.pmid: 22993374
references.citation: Gynecol Oncol. 2009 Jan;112(1):40-6
references.pmid: 18851871
references.citation: Obstet Gynecol. 2007 Oct;110(4):841-8
references.pmid: 17906018
references.citation: Obstet Gynecol. 2011 Jun;117(6):1289-1297
references.pmid: 21606739
references.citation: Obstet Gynecol. 2003 Sep;102(3):499-505
references.pmid: 12962932
references.citation: Semin Surg Oncol. 2000 Jul-Aug;19(1):3-10
references.pmid: 10883018
references.citation: Br J Cancer. 2011 Mar 1;104(5):863-70
references.pmid: 21304524